Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Multiple Myeloma /von 2017-01-01 / Curr Cancer Drug Targets 2017;17(9):782-805PD-1 blockade enhances the vaccination-induced immune response in glioma
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2016-07-07 / JCI Insight 2016 Jul;1(10)Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
/in Checkpoint-Inhibitors, International Publications /von 2016-06-21 / Immunity 2016 06;44(6):1255-69Emerging immunotherapies for glioblastoma
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2016-06-01 / Expert Opin Emerg Drugs 2016 Jun;21(2):133-45Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2016-01-06 / Viruses 2016 Jan;8(1)Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors
/in Checkpoint-Inhibitors, International Publications /von 2015-09-01 / Cancer Biol Med 2015 Sep;12(3):201-8Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
/in Breast Cancer, Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2015-06-02 / Front Immunol 2015;6:271Classifying Cancers Based on T-cell Infiltration and PD-L1
/in Checkpoint-Inhibitors, International Publications /von 2015-06-01 / Cancer Res. 2015 Jun;75(11):2139-45Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
/in Checkpoint-Inhibitors, International Publications /von 2015-04-09 / Cell 2015 Apr;161(2):205-14
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de